Survival in unresectable hepatocellular carcinoma treated with a new immune checkpoint and anti-angiogenic drug combination. Mezzacappa C. Gastroenterology 2023 Sep 6:S0016-5085(23)04976.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mezzacappa C. Survival in unresectable hepatocellular carcinoma treated with a new immune checkpoint and anti-angiogenic drug combination. Gastroenterology 2023 Sep 6:S0016-5085(23)04976.
PMID: 37683705